Andreas Reichel

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Protein Protein

Decision Making

Top Venues

Clinical pharmacology and therapeutics

Drug metabolism and disposition: the biological fate of chemicals

Pharmaceuticals (Basel, Switzerland)

Bayer AG

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bayer AG

Germany

VP, Head :: Research Pharmacokinetics

Schering AG

Germany

Head :: Research Pharmacokinetics

Roche (Switzerland)

Switzerland

Scientist :: DMPK

Publications

Robin Thomas Ulrich Haid, Andreas Reichel
Transforming the Discovery of Targeted Protein Degraders: The Translational Power of Predictive PK/PD Modeling. Clinical pharmacology and therapeutics 116 (3) (2024)
Robin Thomas Ulrich Haid, Andreas Reichel
Transforming the Discovery of Targeted Protein Degraders: The Translational Power of Predictive PK/PD Modeling. Clinical pharmacology and therapeutics (2024)
Christian Lechner, Ursula Mönning, Andreas Reichel, Gert Fricker
Potential and Limits of Kidney Cells for Evaluation of Renal Excretion. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Cornelius Trünkle, Christian Lechner, Daniel Korr, Léa Bouché, Naomi Barak, Amaury E Fernández-Montalván, Roderich D Süssmuth, Andreas Reichel
Concentration Dependence of the Unbound Partition Coefficient Kpuu and Its Application to Correct for Exposure-Related Discrepancies between Biochemical and Cellular Potency of KAT6A Inhibitors. Drug metabolism and disposition: the biological fate of chemicals 48 (7) (2020)